Posted in | News | Gold

Amlib Begins 5,000 m, 97 Drill Holes Program at Zwedru MDA

Amlib Holdings Plc (the “Company”) announces that the Phase 1 exploration drilling programme at the Zwedru Project (see Figure 1) commenced on the 11th March 2013.

Figure 1; Zwedru MDA boundaries, structural trends and planned drill sections

The planned programme consists of 97 drill holes for a total of 5,000m of NQ sized drilling. The programme will target the coincident aeromagnetic and soil geochemical gold anomalies (>100ppb Au) that have been delineated by the Company’s exploration team over a strike length of approximately 12km. The drilling will comprise of between 3 to 6 'heel to toe' short (60m to 120m) inclined diamond drill holes in order to evaluate the hard rock validity to the surface gold anomalies.

Amlib Drilling Services (Liberia) Inc. have been engaged to conduct this drill programme using their recently acquired Ingetrol MD3 Explorer Plus man portable diamond drill rig, which is capable of drill to a depth of 400m with NQ size core.

The programme is helicopter supported in order to ensure maximum efficiency and quick drill moves.

Mark Pryor, VP Exploration commented; “I am extremely excited by the start of the initial drill programme along this major Birimian hosted gold/aeromag anomaly. We have numerous high priority target zones where cross cutting NW trending structures dislocate the major NE trending gold/aeromag feature and it is these zones that characteristicly host the major Birimian gold deposits in the West African Shield”.

Qualified Persons

Mark J Pryor, Pr.Sci.Nat., VP Exploration for Amlib Holdings Plc. is the Qualified Person as defined by NI 43-101 for the project discussed above and has read and approved the contents of this release.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.